To further assess whether tumor-intrinsic Ulk1 deletion affects immune cell composition in vivo, we used syngeneic orthotopic models by injecting KPC sgSC (Ulk1 WT) and KPC sgUlk1 (Ulk1 KO) cells into the pancreas of immunocompetent C57BL/6J mice. The gene discussed is ULK1; the disease is neoplasm.